KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Staphylococcus hominis (coagulase-negative + mupirocin-resistant)

• Staphylococcus hominis
• Staphylococcus hominis (214)
• Staphylococcus hominis (217)
• Staphylococcus hominis (218)
• Staphylococcus hominis (coagulase-negative + mupirocin-resistant)
• Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible)
• Staphylococcus hominis (coagulase-negative + oxacillin-resistant)
• Staphylococcus hominis (coagulase-negative + oxacillin-susceptible)
• Staphylococcus hominis (coagulase-negative)
• Staphylococcus hominis (F10)
• Staphylococcus hominis (LQC 5012)
• Staphylococcus hominis (methicillin-resistant)
• Staphylococcus hominis (methicillin-susceptible)
• Staphylococcus hominis (NCTC 11320)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8